Literature DB >> 3165726

Elimination of leukemic cells by laser photodynamic therapy.

K S Gulliya1, J W Fay, R M Dowben, S Berkholder, J L Matthews.   

Abstract

We studied the effects of 514-nm laser light-induced merocyanine 540 (MC540)-mediated toxicity on both leukemic and normal bone marrow (BM) cells. Acute promyelocytic leukemia (HL-60) cells were incubated with MC540 (20 micrograms/ml) and exposed to 93.6 J/cm2 irradiation at a 514-nm wavelength. Normal bone marrow cells were treated under similar conditions. At this dose, 99.9999% of the leukemic cells were killed while 55% of the BM cell survived. Of the granulocyte-macrophage colony-forming cells (CFU-GM), 27% also survived this treatment. Photosensitization of a mixture of irradiated BM cells mixed with an equal number of nonirradiated HL-60 cell did not interfere with the killing of HL-60 cells. There was no significant reduction in the viability of cells when exposed to the laser light alone. In summary, laser light-induced photosensitization with MC540 has a selective cytotoxicity to leukemic cells; therefore, this procedure may be useful for purging neoplastic cells from autologous BM.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3165726     DOI: 10.1007/bf00273413

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  25 in total

Review 1.  Dye indicators of membrane potential.

Authors:  A S Waggoner
Journal:  Annu Rev Biophys Bioeng       Date:  1979

2.  Changes in axon fluorescence during activity: molecular probes of membrane potential.

Authors:  L B Cohen; B M Salzberg; H V Davila; W N Ross; D Landowne; A S Waggoner; C H Wang
Journal:  J Membr Biol       Date:  1974       Impact factor: 1.843

3.  Effects of ultraviolet radiation on human epidermal cell alloantigen presentation: initial depression of Langerhans cell-dependent function is followed by the appearance of T6- Dr+ cells that enhance epidermal alloantigen presentation.

Authors:  K D Cooper; P Fox; G Neises; S I Katz
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

4.  Photodynamic action of merocyanine 540 on artificial and natural cell membranes: involvement of singlet molecular oxygen.

Authors:  B Kalyanaraman; J B Feix; F Sieber; J P Thomas; A W Girotti
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

Authors:  B R Bloom; B Bennett
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

6.  Dye-mediated photosensitization of murine neuroblastoma cells.

Authors:  F Sieber; M Sieber-Blum
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

7.  Dye-mediated photolysis of normal and neoplastic hematopoietic cells.

Authors:  F Sieber; R K Stuart; S D Rowley; S J Sharkis; L L Sensenbrenner
Journal:  Leuk Res       Date:  1987       Impact factor: 3.156

8.  Photoradiation models for the clinical ex vivo treatment of autologous bone marrow grafts.

Authors:  J Atzpodien; S C Gulati; A Strife; B D Clarkson
Journal:  Blood       Date:  1987-08       Impact factor: 22.113

Review 9.  Human myeloid leukemia cell lines: a review.

Authors:  H P Koeffler; D W Golde
Journal:  Blood       Date:  1980-09       Impact factor: 22.113

10.  In vitro effect of UV radiation on immune function and membrane markers of human Langerhans cells.

Authors:  J Czernielewski; P Vaigot; D Asselineau; M Prunièras
Journal:  J Invest Dermatol       Date:  1984-07       Impact factor: 8.551

View more
  2 in total

1.  Biodistribution and toxicity of photoproducts of merocyanine 540.

Authors:  S Pervaiz; M Battaglino; J L Matthews; K S Gulliya
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

2.  A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplants.

Authors:  A Nahimana; D Aubry; L Lagopoulos; P Greaney; A Attinger; S Demotz; K M Dawson; M Schapira; J Tschopp; M Dupuis; M A Duchosal
Journal:  Blood Cancer J       Date:  2011-12-09       Impact factor: 11.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.